Guizhou Xinbang Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002390.SZ

Guizhou Xinbang Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2023: USD 0.02

Guizhou Xinbang Pharmaceutical Co., Ltd. EPS (Diluted) is USD 0.02 for the year ending December 31, 2023, a 21.50% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Guizhou Xinbang Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2022 was USD 0.02, a -47.38% change year over year.
Guizhou Xinbang Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2021 was USD 0.03, a 96.12% change year over year.
Guizhou Xinbang Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2020 was USD 0.02, a -21.76% change year over year.
Guizhou Xinbang Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2019 was USD 0.02, a 118.52% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Shenzhen Stock Exchange: 002390.SZ

Guizhou Xinbang Pharmaceutical Co., Ltd.

CEO	Ms. Lingzhong Kong
IPO Date	April 16, 2010
Location	China
Headquarters	Intersection of Hangtian Avenue and Xint
Employees	5,149
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of Chinese herbal medicines and biological drugs in China and internationally. It offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipyretic analgesic, cold medication, gynecological treatment, and anti-infective drugs. The company was founded in 1995 and is headquartered in Guiyang, China.

Key trends

Past 5 years